Lifeward expects 2026 revenue similar to 2025 following Oratech acquisition and $10M convertible note financing
Lifeward Ltd. Ordinary Shares · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · Now $7.95
+12% in 7d after detection
Post-detection moves
1h
—
1d
-1.8%
3d
-3.1%
7d
+12%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS